Umbilical vein administration of oxytocin for the management of retained placenta: Is it effective?
- 1 May 1991
- journal article
- clinical trial
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 164 (5) , 1216-1219
- https://doi.org/10.1016/0002-9378(91)90685-k
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Randomisation and baseline comparisons in clinical trialsThe Lancet, 1990
- Removing a retained placenta by oxytocin—A controlled studyAmerican Journal of Obstetrics and Gynecology, 1989
- Influence of umbilical vein administration of oxytocin on the third stage of labor: A randomized, double-blind, placebo-controlled studyAmerican Journal of Obstetrics and Gynecology, 1987
- The effect of oxytocin injection into the umbilical vein for the management of the retained placentaAmerican Journal of Obstetrics and Gynecology, 1987
- Oxytocin injection into the umbilical vein in women with retained placenta: A questionable methodAmerican Journal of Obstetrics and Gynecology, 1986
- Intra-umbilical vein oxytocin in the management of retained placenta. A double blind placebo controlled studyJournal of Obstetrics and Gynaecology, 1986
- Rapid falls in maternal serum alpha-fetoprotein concentrations.Journal of Clinical Pathology, 1985
- A new method for the management of the retained placentaAmerican Journal of Obstetrics and Gynecology, 1983
- Detection and measurement of fetomaternal haemorrhage: serum alpha-fetoprotein and the Kleihauer technique.BMJ, 1977